SEC Form 4 · accession 0001179110-16-018546
Editas Medicine, Inc. · EDIT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Katrine Bosley
Officer — President and CEO · Director · 10% Owner
Period of report
Feb 3, 2016
Accepted (ET)
Feb 4, 2016 · 4:51 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001650664
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $16.00 | Feb 3, 2016 | A | 38,461 | A | — | Feb 2, 2026 | Common Stock | 38,461 | 38,461 | D |
Explanation of responses
- F1This option was granted on February 3, 2016 and is scheduled to vest over four years with one quarter of the shares scheduled to vest on February 2, 2017, and the remaining shares scheduled to vest in equal monthly installments of 1/48th of the shares thereafter through February 2, 2020.